RE: RE: RE: Why I would expect to go over $1.50Ditto, Jimmy!
Glad my series of questioning and deductions is working. Hope more people can come to the same conclusion as we.
All these talk of buy-out and speculations of Endo releasing data in the next few days, weeks and months are all causing undue expectations,impatience and frustration, worst of all, nervousness.
The truth of the matter is we have been rather lucky to have come across a stock that showed enough "leaks" for us to reasonably "bet" on a" probable" success story. Until the day of official approval, it remains a bet. There will be many stages of bet, i.e. PIIIb results, FDA approval, marketing and eventual sales numbers. Every one of these stages will test our patience and belief in this drug. We might as well use this period to give us some training, if we want to stay for the long haul to participate in the final big prize.
BNC management is obviously also waiting. Until the day of full approval, they will not have enough fund for any more Urocidin efficacy testings for other cancers, which will be needed to attract more development partners. That's why they get rid of the human drug test director to save the salary for now. At the mean time, they focus on what they know best and developments that requires less funds to continue the expansion of its pipeline. Smart move.
For now, all we can do is wait. The current everyday fluctuations only matter to day-traders.
BTW, I am encourage to see some big name players in Australia as major holders, that's a good vote of confidence.